✦ LIBER ✦

The use of androstan-3, 11, dione-17β-hydroxy, 17-methyl (compound NSC 19605) in the treatment of advanced breast cancer

✍ Scribed by Fred J. Ansfield; Kenneth B. Olson; Opal Rasch

Publisher: John Wiley and Sons
Year: 1962
Tongue: English
Weight: 332 KB
Volume: 15
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(196203/04)15:2<330::aid-cncr2820150215>3.0.co;2-n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2α,3α-epithio-5α-androstan-17β-ol in the

2α,3α-epithio-5α-androstan-17β-ol in the treatment of advanced breast cancer. Japanese cooperative group of hormonal treatment for breast cancer

✍ CHAIRMAN Masao Fujimorimd 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 1 views

2α, 3α-Epithio-5α-androstan-17β-YL 1-met

2α, 3α-Epithio-5α-androstan-17β-YL 1-methoxycyclopentyl ether in the treatment of advanced breast cancer

📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 1 views

Hormonal therapy in cancer of the breast

Hormonal therapy in cancer of the breast, XIII. The effect of 9α-fluoro-17α-methyl-Δ4-androsten-3-one-11β,17β-diol (fluoxymesterone) therapy on clinical course and hormonal excretion

✍ Albert Segaloff; C. Y. Bowers; Edward L. Rongone; Paul J. Murison; Joseph V. Sch 📂 Article 📅 1958 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 1 views

HE ANDROGENIC steroids most effective in T the treatment of metastatic breast cancer have all been potent androgens. T o date, the less potent androgens have been less effective.3~4 Hence, when an androgen more potent than testosterone or methyltestosterone became available it was thought important